Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter De Pauw

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nanomedicine (London, England)|June 5, 2013
Nanobodies and their potential applicationsGholamreza Hassanzadeh-Ghassabeh, Nick Devoogdt, Pieter De Pauw, et al.
Talanta|August 28, 2014
Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determinationStéphanie Patris, Pieter De Pauw, Marie Vandeput, et al.
Transplantation|February 10, 2009
Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipientsPieter Gillard, Evy Vandemeulebroucke, Bart Keymeulen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 14, 2021
Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead OptimizationPhilippe J-L Y Gevenois, Pieter De Pauw, Steve Schoonooghe, et al.
Current Pharmaceutical Design|September 28, 2016
Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain AntibodiesEma Romao, Francisco Morales-Yanez, Yaozhong Hu, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2015
Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic PatientsZhidong Ling, Pieter De Pauw, Daniel Jacobs-Tulleneers-Thevissen, et al.
Diabetes Research and Clinical Practice|October 26, 2023
Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetesAster K Desouter, Bart Keymeulen, Simke Demeester, et al.
Plos One|June 2, 2017
Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide RatioAnnelien Van Dalem, Simke Demeester, Eric V Balti, et al.
Plos One|December 2, 2016
Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide RatioAnnelien Van Dalem, Simke Demeester, Eric V Balti, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthoodIlse Weets, Valerie Siraux, Jean-Claude Daubresse, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nanomedicine (London, England)|June 5, 2013
Nanobodies and their potential applicationsGholamreza Hassanzadeh-Ghassabeh, Nick Devoogdt, Pieter De Pauw, et al.
Talanta|August 28, 2014
Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determinationStéphanie Patris, Pieter De Pauw, Marie Vandeput, et al.
Transplantation|February 10, 2009
Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipientsPieter Gillard, Evy Vandemeulebroucke, Bart Keymeulen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 14, 2021
Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead OptimizationPhilippe J-L Y Gevenois, Pieter De Pauw, Steve Schoonooghe, et al.
Current Pharmaceutical Design|September 28, 2016
Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain AntibodiesEma Romao, Francisco Morales-Yanez, Yaozhong Hu, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2015
Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic PatientsZhidong Ling, Pieter De Pauw, Daniel Jacobs-Tulleneers-Thevissen, et al.
Diabetes Research and Clinical Practice|October 26, 2023
Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetesAster K Desouter, Bart Keymeulen, Simke Demeester, et al.
Plos One|June 2, 2017
Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide RatioAnnelien Van Dalem, Simke Demeester, Eric V Balti, et al.
Plos One|December 2, 2016
Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide RatioAnnelien Van Dalem, Simke Demeester, Eric V Balti, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthoodIlse Weets, Valerie Siraux, Jean-Claude Daubresse, et al.
Pageof 2